Tralokinumab in Atopic Dermatitis: A Profile of Its Use

Blair, HA

Blair, HA (通讯作者),Springer Nat, Private Bag 65901, Auckland 0754, New Zealand.

CLINICAL DRUG INVESTIGATION, 2022; 42 (4): 365

Abstract

Tralokinumab (tralokinumab-ldrm) [Adbry (TM) (USA); Adtralza (R) (EU)], a human IgG4 monoclonal antibody that binds specifically to interleukin (IL)-1......

Full Text Link